Literature DB >> 12620377

Role of nitric oxide in D-galactosamine-induced cell death and its protection by PGE1 in cultured hepatocytes.

Emilio Siendones1, Dalia Fouad, Amira Mohamed Kamal ElSaid Abou-Elella, Ana Quintero, Pilar Barrera, Jordi Muntané.   

Abstract

Prostaglandin E(1) (PGE(1)) reduces cell death in experimental and clinical manifestations of liver dysfunction. Nitric oxide (NO) has been shown to exert a protective or noxious effect in different experimental models of liver injury. The aim of the present study was to investigate the role of NO during PGE(1) protection against D-galactosamine (D-GalN) citotoxicity in cultured hepatocytes. PGE(1) was preadministered to D-GalN-treated hepatocytes. The role of NO in our system was assessed by iNOS inhibition and a NO donor. Different parameters related to apoptosis and necrosis, NO production such as nitrite+nitrate (NO(x)) release, iNOS expression, and NF-kappaB activation in hepatocytes were evaluated. The inhibition of iNOS reduced apoptosis induced by D-GalN in hepatocytes. PGE(1) protection against D-GalN injury was associated with its capacity to reduce iNOS expression and NO production induced by D-GalN. Nevertheless, iNOS inhibition showed that protection by PGE(1) was also mediated by NO. Low concentrations of a NO donor reduced D-GalN injury with a decrease in the extracellular NO(x) concentration. High concentrations of the NO donor enhanced NO(x) concentration and increased cell death by D-GalN. The present study suggests that low NO production induced by PGE(1) preadministration reduces D-GalN-induced cell death through its capacity to reduce iNOS expression and NO production caused by the hepatotoxin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620377     DOI: 10.1016/s1089-8603(02)00182-9

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  5 in total

1.  Nitric oxide and cancer.

Authors:  Jordi Muntané; Manuel De la Mata
Journal:  World J Hepatol       Date:  2010-09-27

2.  Antitumoral gene-based strategy involving nitric oxide synthase type III overexpression in hepatocellular carcinoma.

Authors:  Á J De la Rosa; Á Rodríguez-Hernández; R González; S Romero-Brufau; E Navarro-Villarán; L Barrera-Pulido; S Pereira; L M Marín; F López-Bernal; J M Álamo; M A Gómez-Bravo; F J Padillo; J Muntané
Journal:  Gene Ther       Date:  2015-07-23       Impact factor: 5.250

3.  Anti‑apoptotic effects of human placental hydrolysate against hepatocyte toxicity in vivo and in vitro.

Authors:  Dong-Ho Bak; Jungtae Na; Mi Ji Choi; Byung Chul Lee; Chang Taek Oh; Jeom-Yong Kim; Hae Jung Han; Moo Joong Kim; Tae Ho Kim; Beom Joon Kim
Journal:  Int J Mol Med       Date:  2018-08-17       Impact factor: 4.101

4.  Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats.

Authors:  M B Herrera; V Fonsato; S Gatti; M C Deregibus; A Sordi; D Cantarella; R Calogero; B Bussolati; C Tetta; G Camussi
Journal:  J Cell Mol Med       Date:  2009-07-24       Impact factor: 5.310

5.  Design, synthesis and hepatoprotective activity of analogs of the natural product goodyeroside A.

Authors:  Feng Zhang; Bei Han; Peng Li; Ziyun Lin; Dali Yin; Yan Li; Jialiang Zhong; Haihong Huang
Journal:  Molecules       Date:  2013-02-01       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.